Rohto Pharmaceutical Co., Ltd. operates within the Toilet preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Rohto Pharmaceutical Co., Ltd. with three other
companies in this sector in Japan:
Rizap Group Inc
sales of 136.20 billion Japanese Yen [US$1.21 billion]
of which 50%
was Health & Beauty-Related Businesses),
(102.56 billion Japanese Yen [US$908.71 million]
of which 33%
was China Business), and
(109.02 billion Japanese Yen [US$965.91 million]
of which 61%
was Cosmetics Business).
During the year ended March of 2018, sales at
Rohto Pharmaceutical Co., Ltd. were ¥171.74 billion (US$1.52 billion).
increase of 11.1%
versus 2017, when the company's sales were ¥154.60 billion.
Sales of Operating Segment-America saw an increase
that was more than double the company's growth rate: sales were up
26.7% in 2018, from
¥6.91 billion to ¥8.75 billion.
Rohto Pharmaceutical Co., Ltd. also saw significant increases in sales in
Operating Segment-Europe (up 17.8% to ¥8.28 billion)